These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12759155)

  • 61. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
    Dubertret C; Bidard I; Adès J; Gorwood P
    Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mental health differences between frequent cannabis users with and without dependence and the general population.
    van der Pol P; Liebregts N; de Graaf R; Ten Have M; Korf DJ; van den Brink W; van Laar M
    Addiction; 2013 Aug; 108(8):1459-69. PubMed ID: 23530710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cannabis use patterns and their association with DSM-IV cannabis dependence and gender.
    Noack R; Höfler M; Lueken U
    Eur Addict Res; 2011; 17(6):321-8. PubMed ID: 22042220
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Depressive and anxiety disorders predicting first incidence of alcohol use disorders: results of the Netherlands Study of Depression and Anxiety (NESDA).
    Boschloo L; Vogelzangs N; van den Brink W; Smit JH; Veltman DJ; Beekman AT; Penninx BW
    J Clin Psychiatry; 2013 Feb; 74(12):1233-40. PubMed ID: 24434092
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Screening for anxiety in an epidemiological sample: predictive accuracy of questionnaires.
    Hoyer J; Becker ES; Neumer S; Soeder U; Margraf J
    J Anxiety Disord; 2002; 16(2):113-34. PubMed ID: 12194539
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Positive and negative life events and personality traits in predicting course of depression and anxiety.
    Spinhoven P; Elzinga BM; Hovens JG; Roelofs K; van Oppen P; Zitman FG; Penninx BW
    Acta Psychiatr Scand; 2011 Dec; 124(6):462-73. PubMed ID: 21848705
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Does cannabis use increase anxiety disorders? A literature review.
    Shalit N; Lev-Ran S
    Curr Opin Psychiatry; 2020 Jan; 33(1):8-13. PubMed ID: 31592815
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Epidemiology of DSM-5 Cannabis Use Disorders Among U.S. Adults: Science to Inform Clinicians Working in a Shifting Social Landscape.
    Compton WM; Baler R
    Am J Psychiatry; 2016 Jun; 173(6):551-3. PubMed ID: 27245184
    [No Abstract]   [Full Text] [Related]  

  • 71. Cannabis and anxiety: a critical review of the evidence.
    Crippa JA; Zuardi AW; Martín-Santos R; Bhattacharyya S; Atakan Z; McGuire P; Fusar-Poli P
    Hum Psychopharmacol; 2009 Oct; 24(7):515-23. PubMed ID: 19693792
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does morning affect contribute to daily Cannabis use?
    Testa M; Wang W; Derrick JL; Brown WC; Collins RL
    Addict Behav; 2019 Aug; 95():64-69. PubMed ID: 30856545
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Scoping Review of Associations Between Cannabis Use and Anxiety in Adolescents and Young Adults.
    Stiles-Shields C; Archer J; Zhang J; Burnside A; Draxler J; Potthoff LM; Reyes KM; Summersett Williams F; Westrick J; Karnik NS
    Child Psychiatry Hum Dev; 2023 Jun; 54(3):639-658. PubMed ID: 34724134
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cannabis use and anxiety: is stress the missing piece of the puzzle?
    Temple EC; Driver M; Brown RF
    Front Psychiatry; 2014; 5():168. PubMed ID: 25505428
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Using the experience sampling method to support clinical practice: An illustration with problematic cannabis use.
    Piccirillo ML; Enkema MC; Foster KT
    Psychother Res; 2024 Feb; 34(2):241-260. PubMed ID: 36976153
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents.
    Wittchen HU; Fröhlich C; Behrendt S; Günther A; Rehm J; Zimmermann P; Lieb R; Perkonigg A
    Drug Alcohol Depend; 2007 Apr; 88 Suppl 1():S60-70. PubMed ID: 17257779
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
    Moore TH; Zammit S; Lingford-Hughes A; Barnes TR; Jones PB; Burke M; Lewis G
    Lancet; 2007 Jul; 370(9584):319-28. PubMed ID: 17662880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology.
    Chabrol H; Ducongé E; Casas C; Roura C; Carey KB
    Addict Behav; 2005 May; 30(4):829-40. PubMed ID: 15833585
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Exploring the association between cannabis use and depression.
    Degenhardt L; Hall W; Lynskey M
    Addiction; 2003 Nov; 98(11):1493-504. PubMed ID: 14616175
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The association between cannabis use and anxiety disorders: Results from a population-based representative sample.
    Feingold D; Weiser M; Rehm J; Lev-Ran S
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):493-505. PubMed ID: 26775742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.